36 CURRICULUM VITAE SHLOMO MELAMED MD NAME SHLOMO MELAMED

CURRICULUM VITAE BLANCA GARCÍA
5 RESUMEN DE CURRICULUM VITAE 1 DATOS
9 CURRICULUM VITAE I PERSONAL HOWARD A

CURRICULUM VITAE DR ABDELGHAFFAR M ELDEMERDASH
CURRICULUM VITAE JOSÉ JUAN BONOME BÁRCENA
CURRICULUM VITAE DR CONSTANTINO MORERA PEREZ PROFESOR

CURRICULUM VITAE

36


CURRICULUM VITAE


SHLOMO MELAMED, M.D



Name: Shlomo Melamed, M.D.


Identity No.: 817389


MD Licence # 11328

Ophthalmology Specialist Licence # 6601


Place of Work: Goldschleger Eye Institute,

The am Rothberg Glaucoma Center

Chaim Sheba Medical Center

Tel Hashomer, 52621 Israel


Phone No.: 03-5302046


Home Address: 43 Hashalom St., Ra’anana, Israel


Phone No.: 09-7717307 , 052-866736


Date and Place of Birth: 14.3.1948, Israel


Zahal (Israeli) Military Service: enlisted – 21.10.65

discharged - 1973


Martial Status: Married No. of Children: 3



  1. EDUCATION


Period of Study

University

Subject

Degree

1967-1973

Hebrew University

Medicine

M.D. 1974

1972-1973

Mount Sinai Hospital,

New York

Internal Medicine


1973-1974

Hadassah Hospital, Jerusalem

Internship

Lic. No. 11328


1975-1976

Hadassah Hospital, Jerusalem

Internal Medicine


1976-1981

Beilinson Medical Center, Sackler School of Medicine

Ophthalmology

Lic. No. 6601



Date of Receiving Specialization Certificate: 1981


Title of Doctoral Dissertation: Recurrence of Intracranial Meningioma.


Name of Supervisors: 1. Prof. A. Sahar

2. Prof. A. Beller








B. FURTHER STUDIES


Period of Study

University

Subject

Degree

1983-1984

Harvard, Boston

Glaucoma

Fellow

1984-1985

Harvard Medical School, Boston

Glaucoma, Clinical

Fellow

1985

University of California,

San Francisco

Glaucoma, Surgery


1985

National Eye Institute, Washington D.C.

Bio Statistics and Clinical Studies




C. ACADEMIC EXPERIENCE


Period of Study

Institution

Department

Rank

1985-1987

Harvard Medical School, Boston

Ophthalmology

Instructor

1985-1989

Tufts – New England Medical School

Ophthalmology

Instructor

1985

International Eye Foundation,

Washington D.C.

Ophthalmology

Visiting Professor

1985-1988

Harvard Medical School, Boston

Ophthalmology

Member of Teaching Committee

1985-1988

Harvard Medical School, Boston

Ophthalmology

Member of Fellowship Committee

1987

Sackler School of Medicine, Tel Aviv University

Ophthalmology

Senior Lecturer

1988

Harvard Medical School, Boston

Ophthalmology

Assistant Professor (nominated)

1991


Sackler School of Medicine, Tel Aviv University

Ophthalmology

Associate Professor

2006 Sackler School of Ophthalmology Full Professor

Medicine, Tel Aviv

University


2008 Incumbent, The Zuker-Sussman Chair for Glaucoma Research,

Sackler Medical School, Tel Aviv University













  1. D. CLINICAL AND TEACHING EXPERIENCE


Period

Institution

Department

Rank

1976-1980

Beilinson Medical Center

Ophthalmology

Resident

1981

Beilinson Medical School

Ophthalmology

Senior Ophthalmologist

1982-1983

General Israel Sick Fund (Kupat Holim)

Medical Administration

Medical Director

1983-1985

Massachusetts Eye and Ear Infirmary

Glaucoma Service

Fellow

1985

Island of St. Lucia

Ophthalmology

Visiting Professor (International Eye Foundation Co-Director)

1985-1986

Massachusetts Eye and ear Infirmary

Glaucoma Service

Assistant Director

1985-1986

Tufts New England Medical Center

Ophthalmology

Attending Senior

1985-1988

Massachusetts Eye and Ear Infirmary

Ophthalmology

Member of Ambulatory Care Committee

1985-1988

Massachusetts Eye and Ear Infirmary

Ophthalmology

Member of Pharmaceutical Committee

1986-1987

Chaim Sheba Medical Center, Tel Hashomer

Ophthalmology

Director Glaucoma Service

1987-1988

Massachusetts Eye and Ear Infirmary

Glaucoma Service

Acting Director

1989-


Chaim Sheba Medical Center, Tel Hashomer

Ophthalmology

Director, Glaucoma Service



1991

Founder and president the International Glaucoma Symposium (I.G.S )



1998

MSD, Organizer, University Course on Glaucoma, Cambridge, England



1998

Ministry of Foreign Affairs, Organizer of Surgery in Papua, New Guinea Project



1999

Ministry of Foreign Affairs, Organizer, Surgical Delegation, Bolivia.



1999

MSD,Organizer, University Course on Glaucoma, Dublin, Ireland







1999

Ministry of Health, Member Medical Device Committee ( “ AMAR “)








2000

Ministry of foreign affairs organizer, surgical delegation in Micronesia, Pacific Ocean.



2000

Founder and director, the Glaucoma Molecular Biology Laboratory, Sheba Medical Center.



2001

President, IGS, Prauge




2002

Organizer, Ministry of foreign affairs , Surgical delegation, Micronesia

Research project in Pingelap Island







2003

President, IGS, Barcelona



2003

Tutor , The European Glaucoma inter-active course , Girona , Spain



2004

Organizer, Ophthalmic Surgical and Teaching Expedition to Hyderabad and Utra-Pradesh, India



2004

Founder and Organizer, the 1st Glaucoma Inter-active course for residents and young ophthalmologists, Maale Hahamisha, Israel.



2005

Organizer, the 2nd Interactive course for Retina and Glaucoma, Shefayim, Israel.



2005



2007


2009



2009








2009




2010

President, the 5th IGS

Capetown, South Africa.


President, the 6th IGS

Athens , Greece

Program Committee Member , WGC, Boston


Chair and Founder, the World glaucoma Projects Committee (WGPC) – an international surgical education and outreach program in the developing world


Medical Director , "Tikun Olam", Use of medical Cannabis in medicine


Head of delegation, surgical/educational project in Abuja, Nigeria








E. ACADEMIC AND PROFESSIONAL AWARDS


  1. Prizes


Year

Institution

Award

1972

Hadassah Hospital

Best Student Award


2. Fellowships


Year

Institution

Fellowship

1983-4

Harvard Medical School –

Howe Lab. Of Ophthalmology

Glaucoma Research fellowship fight for sight grant

1984-5

Harvard Medical School – M.E.E.I

Glaucoma Clinical Fellowship


3. Awards


2003

Richard Stein award

Tel Aviv University

2004

The Greek Ophthalmological Society Golden Award for excellence in Glaucoma research

Athens, Greece










4. Patents


Year

Inventor patent no. 6059772

2000

Apparatus and method for treating glaucoma using a Gonioscopic laser for Trabecular ablation




5. Grants


Year

Institution

Grant

1978-9

Beilinson Medical Center-Dept. of Ophthalmology

Merck, Sharp & Dohme Grant (Effect of Timolol on IOP)

1983-5

Harvard Medical School – M.E.E.I

Allergan Grant (Effect of Levobunolol on IOP)

1984-8

Harvard Medical School – M.E.E.I

Glaucoma Laser Trial (GLT) National Eye Inst. Grant

1984-6

Harvard Medical School – M.E.E.I

Allergan Inc. Grant (Bunolol & Betaxolol Treatment in Glaucoma)

1984-6

Harvard Medical School – M.E.E.I

Merck, Sharp & Dohme Grant (Timolol vs. Betaxolol in Glaucoma)

1985

Harvard Medical School – M.E.E.I

Allergan Inc. Grant (FML following Laser Trabeculoplasy)

1986

Goldschleger Eye Institute,

Tel Hashomer

Allergan Inc. Grant (Betagan Treatment in Glaucome)

1987-8

Harvard Medical School – M.E.E.I

SLT Nd-YAG Laser Grant (Nd-YAG Laser Cyclophotocoagulation in Glaucoma)

1989

Goldschleger Eye Institute,

Tel Hashomer

Allergan Inc. Grant (Bunolol + Propine Treatment in Glaucoma)

1989

Goldschleger Eye Institute,

Tel Hashomer

Candela Laser Corp. (Flashlamp-Pumped Pulsed-Dye Laser Filtration in Glaucoma)

1990

Goldschleger Eye Institute,

Tel Hashomer

Shauder Grant, Tel Aviv University (Photoselective Surgery in Glaucoma)





Year


Institution


Grant

1990

Goldschleger Eye Institute,

Tel Hashomer

Candela Laser Corp. Chairman of Multicenter Study of Laser Internal Filtration (England, Germany, Japan, Switzerland)

1990

Goldschleger Eye Institute,

Tel Hashomer

MK-507 compared with -blockers in Glaucoma. Merck, Sharp & Dohme Grant , 28,000.- $

1991

Goldschleger Eye Institute,

Tel Hashomer

Pilocarpine-SME – a new carrier for Glaucoma. Grant given by Pharmos Company, Israel

1991

Goldschleger Eye Institute,

Tel Hashomer

Ethacrynic acid in Glaucoma. Grant given by Telor Company, USA , 42000.- $

1993

Goldschleger Eye Institute,

Tel Hashomer

Adaprolol_SME in Glaucoma. Grant given by Pharmos Inc., Israel

1993

Goldschleger Eye Institute,

Tel Hashomer

Latanaprost (Prostaglandins) in Glaucoma. Grant given by Kabi-Pharmacia, Uppsala, Sweden ,

18000.- $

1993

Goldschleger Eye Institute,

Tel Hashomer

Ethacrynic acid after cataract surgery.

Grant given by Telor Inc., USA , 20000.- $

1994

Goldschleger Eye Institute,

Tel Hashomer

Brimonidine in Glaucoma.

Grant given by Allergan Inc., USA , 18000.- $

1994

Goldschleger Eye Institute,

Tel Hashomer

HU-11 in Glaucoma.

Grant given by Pharmos Inc., Israel

1994

Goldschleger Eye Institute,

Tel Hashomer

1,000,000 US$ – Donation given by Mr. Samuel Rothberg for the establishment for the “Sam Rothberg Glaucoma Center”.

1995

Goldschleger Eye Institute,

Tel Hashomer

Hydralazine in Glaucoma.Grant given by Ciba-Vision, Switzerland

1996

The Sam Rothberg Glaucoma Center, Tel Hashomer

A Joint Project of Screening Glaucoma with the Mobile Unit System, with Sha’are-Zedek Hospital , 40,000.- $ per year

1997

The Sam Rothberg Glucoma Center, Tel Hashomer

Use of Co-Sopt in Glaucoma by M.S.D, 12,000.- $

1998

The Sam Rothberg Glucoma Center, Tel Hashomer

Rescula, a new drug for Glaucoma.

Grant given by Ciba-Vision , 60000.- $

1998

The Sam Rothberg Glaucoma Center, Tel Hashomer

Surgical Consultation Project in Papua, New Guinea, by PNG Government

1998

The Sam Rothberg Glaucoma Center, Tel Hashomer

Donation for establishing the Ophthalmic Molecular Biology Laboratory (in process) 1,600,000.- $ from 2001 to 2005

1999

The Sam Rothberg Glaucoma Center, Tel Hashomer

Memantine Study Neuro Protecting Treatment. Grant given by Allergan , 120,000.- $ from 2000-2005

1999

The Sam Rothberg Glaucoma Center, Tel Hashomer

Hypotensive lipids for Glaucoma.

Grant given by Allergan, 30,000.- $

2001

The Sam Rothberg Glucoma Center, Tel Hashomer

Travatan vs. latanoprost in glaucoma.

Grant given by Alcon U.S.A , 12,000.- $

2003


The Sam Rothberg Glaucoma Center Tel Hashomer

Travatan – Timolol combination Rx in Glaucoma. Grant given by Alcon USA , 12,000.- $

2003

The Sam Rothberg Glaucoma Center Tel Hashomer

Spheno-Palatine Ganglion Stimulation-effect on retinal perfusion. Grant given by Brainsgate , Israel.

2003

The Sam Rothberg Glaucoma Center Tel Hashomer

Role of Copacson in Glaucoma. Grant given by Teva , Israel. , 5000.- $

2003

The Sam Rothberg Glaucoma Center Tel Hashomer

Neuroprotective effect of AD-4 , a free radical scavenger. Grant given by Novia, Israel.

2004

The Sam Rothberg Glaucoma Center Tel Hashomer

Titanium Saphire Laser Trabeculoplasty in glaucoma. Grant given by Solx Ltd., Boston., 15000.- $

2004

The Sam Rothberg Glaucoma Center, Tel Hashomer

A novel Golden Glaucoma Shunt implantation into the Supraciliary space. Grant given by Solx Ltd., Boston., 15000.- $

2004






2009




2009

The Sam Rothberg Glaucoma Center, Tel Hashomer





The Sam Rothberg Glaucoma Center, Tel Hashomer



The Sam Rothberg Glaucoma Center

Lumigan Vs. Xalatan in Pseudoexfoliative Glaucoma. A multi-center study with Greece, Turkey and Hungary. Grant given by Allergan, USA.


CO2 Laser Assisted Deep Sclerectomy in Glaucoma patients. Grant given by IOPtima Ltd. , Israel.


Objective Perimetry in Retinitis Pigmentosa and Glaucoma patients. Grant given by Maratier Fund, together with Dr. Rotenshtreich.





All grants given as a Principal investigator

2002


The Sam Rothberg Molecular Biology Laboratory

Role of MAP Kinase pathway in Glaucoma: mechanism and new treatment strategy. Grant given by Glaucoma Research Foundation (GRF), USA. , 40,000.- $

2002

The Sam Rothberg Molecular Biology Laboratory

MAP Kinase pathway in Glaucoma. Grant given by Maratier Fund, Israel.

6000.- $

2002

The Sam Rothberg Molecular Biology Laboratory

Role of Collapsin in Retinal Ganglion Cells degenerationin rats with glaucoma. Grant given by Maratier Fund, Israel. , 6000.- $

2003

The Sam Rothberg Molecular Biology Laboratory

The neuroprotective effect of Minocycline in the rat glaucoma model. Grant given by Maratier Fund, Israel. 6000.- $

2003

The Sam Rothberg Molecular Biology Laboratory

Minocycline in the Rat Glaucoma Model. Grant given by Vladimir Shreiber fund for Medical Research, Israel., 11000.- $

2004







The Sam Rothberg Molecular Biology Laboratory

Efficacy of Copaxon as a neuroprotective agent in the rat glaucoma model. Grant given by Teva Pharmaceutical. , 24,000.- $



All grants were given to Dr. H. Verbin – Levkovitch and Prof. S. Melamed as co-investigators




6. Passed Good Clinical Practice (GPC) Course, by Bio-Medical Design Ltd., 2008






  1. ACTIVE PARTICIPATION IN SCIENTIFIC MEETINGS


Year

Name of Meeting (City, Country)

1979

American Academy of Ophthalmology (San Francisco, USA)

1981

8th Asia-Pacific Congress of Ophthalmology (Bangkok, Thailand)

1984

Lasers in Ophthalmology (Jerusalem, Israel)

1984

ARVO Meeting (Sarasota, Florida, USA)

1985

Trabecular Meshwork Research Meeting (Catham, Cape Cod, USA)

1985

New England Ophthalmological Society (Boston, USA)

1985

M.E.E.I. Alumni Meeting (Boston, USA)

1985

University of Kentucky Ophthalomology Meeting (Lexington, Kentucky, USA)

1985

ARVO Meeting (Sarasota, Florida, USA)

1986

M.E.E.I. Alumni Meeting (Boston, USA)

1986

6th Annual Meeting of American Society for Lasers in Medicine and Surgery (Boston, USA)

1986

International Congress of Glaucoma Society (Bussum, Holland)

1986

ARVO Meeting (Sarasota, Florida, USA)

1987

American Academy of Ophthalomology (Dallas, Texas, USA)

1987

ARVO Meeting (Sarasota, Florida, USA)

1988

European Intra-Ocular Lenses Meeting (Brussels, Belgium)

1988

American Academy of Ophthalmology (Las-Vegas, USA)

1989

Ocular Trauma Congress (Tel Aviv, Israel

1989

European Glaucoma Society Meeting (Budapest, Hungary)

1990

International Glaucoma Symposium (Singapore)

1990

International Congress of Ophthalmic Research (Helsinki, Finland)

1990

Laser Photorefractive Surgery (Munich, Germany)

1991

ARVO Meeting (Sarasota, Florida, USA)

1991

International Meeting of Lasers in Ophthalmology (San Francisco, USA)

1991

American Academy of Ophthalmology (Los Angeles, USA)

1991

Organizer, International Glaucoma Symposium (Jerusalem, Israel)

1992

2nd International Symposium on Ocular Trauma (Geneva, Switzerland)

1992

ARVO Meeting (Sarasota, Florida, USA)

1992

European Glaucoma Society Meeting (Amsterdam, Holland)

1992

On Faculty, Lasers in Ophthalmology (Ramat Rachel, Israel)

1992

On Faculty, International Symposium on Lasers in Ophthalmology (Interlaken, Switzerland)

1992/3

Organizer, Continuing Education Course in Ophthalmology, Sackler School of Medicine, Tel Aviv University

1993

Italian Ophthalmological Society Meeting (Rapallo, Italy)

1993

ARVO Meeting (Sarasota, Florida, USA)

1993

Organizer, Europto Lasers in Medicine Congress (Budapest, Hungary)

1994

Greek Glaucoma Society Meeting (Athens, Greece)

1994

ARVO Meeting (Sarasota, Florida, USA)

1994

Organizer, Europto Lasers in Medicine Congress (Lille, France)

1994

American Academy of Ophthalmology (San Francisco, USA)

1994

Israel Ophthalmic Research Meeting (Jerusalem, Israel)

1995

ARVO Meeting (Fort Lauderdale, Florida, USA)

1995

Greek Glaucoma Society Athens, Greece)

1995

Israel Ophthalmic Research Meeting (Zichron Ya’acov, Israel)

Year

Name of Meeting (City, Country)

1996

Glaucoma Imaging Course (boston, USA)

1996

Mediterranean Ophthalmological Society (Rome, Italy)

1996

ARVO Meeting (Fort Lauderdale, Florida, USA)

1996

European Glaucoma Society Meeting (Paris, France)

1996

Joint European Research Meeting – JERMOV (Montpellier, France)

1997

ARVO Meeting (Fort Lauderdale, Florida, USA)

1997

Indian Ophthalmological Society Meeting ( Ahmed Abad, India)

1998

ARVO Meeting (Fort Lauderdale, Florida, USA)

1998

Philippines Glaucoma Society Meeting (Manila, Philippines)

1998

Organizer and President, International Glaucoma Society Meeting (Jerusalem, Israel)

1999

Asia-Pacific Ophthalmology Congress (Manila, Philippines)

1999

American Academy of Ophthalmology (Orlando, U.S.A.)

1999

International Congress of Ophthalmology (Stockholm, Sweden)

1999

Glaucoma in 2000 (Hong Kong)

2000

2000

Ocular Pharmacology Congress (Lisbon, Portugal)

The Spanish ophthalmologgical society ( Madrid, Spain )

2000

American Academy of ophthalmology ( Dallas, USA )

2001

Turkish Glaucoma Society, Izmir, Turkey.

2001

American academy of ophthalmology, New Orleans, U.S.A

2001

President’ the 3rd IGS ( International Glaucoma Symposium ), Prague

2002

Organizer, Glaucoma section,International congress of eye research ( ICER ), Geneva, Switzerland.

2003

President, the 4th IGS, Barcelona, Spain

2003

ARVO, Fort Lauderdale, Florida

2003

The South African Glaucoma Society meeting, Capetown, SA

2003

The German Ophthalmic Surgeons meeting (DOC), Nurenberg, Germany

2003

The European Glaucoma inter-active course, Girona , Spain

2003

The Turkish Ophthalmological Society meeting, Istanbul, Turkey

2003

The Chinese Ophthalmological Society Meeting, Xian, China

2004

The Turkish Glaucoma Society meeting, Antalya, Turkey

2004

The Greek glaucoma society Meeting, Athens, greece

2004

The Russian Glaucoma meeting, Moscow, Russia

2004

2005

2005

2005

2006

2006

2007

2008

2009

2010

The Indian Glaucoma meeting, Hyderabad, India

President, I.G.S , Capetown, South Africa

Dutch Ophthalmological Society meeting, Rotterdam, Holland

The Pensylvania glaucoma society meeting, Pittsburg, USA

The southern European Ophthalmological meeting, Dobrovnik, Croatia

World Congress of Ophthalmology, Hong Kong, China

President, the I.G.S , Athens, Greece

Brasilian Ophthalmological society, Sao Paolo, Brasil

Organizer, program committee – the World Glaucoma Congress, Boston, USA


Organizer, the 1st African Glaucoma summit, Accra, Ghana



  1. MEMBERSHIP IN PROFESSIONAL SOCIETIES


Year

Society

Country

1984

Association for Research in Vision and Ophthalmology

USA

1985

American Association for the Advancement of Science

USA

1985

Israeli Ophthalmological Society

Israel

1986

Glaucoma Society of the International Congress

USA

1986

The Chandler and Grant Society

USA

1987

American Academy of Ophthalmology

USA

1987

American Society for Lasers in Medicine

USA

1987

Israeli Glaucoma Society

Israel

1988

European Glaucoma Society

Holland

1988


American Glaucoma Society

USA

1989

Asian-Pacific Laser Society

Singapore

1990

International Society of Eye Research

Finland

1991

International Society of Ocular Trauma

Israel

1993

Europto Lasers in Medicine Society

Germany

1994

Board Member, Mediterranean Glaucoma Society

Italy

1996

Member, Helsinki Committee for Evaluation of New Medical Instrumentation (“Amar”), Israel Ministry of Health

Israel

1991-2005

President, the International Glaucoma society


2001

Committee member, head of glaucoma section, International congress of eye research. ( ICER )

Geneva


2002

Commttee member, International Society of imaging in the eye ( ISIE )

U.S.A

2002

Committee Member , Maratier Fund , Tel Aviv University Medical School

Israel

2002

Editorial board member, Journal of Ophthalmic Surgery and Lasers

U.S.A

2003

Editorial board member, Ocular Surgery News

U.S.A

2003

Editorial Board, U.S-Chinese Journal of Ophthalmology

China



2004

2008

2008

International Editorial Board, Ophthalmologia (Pan Helenic )

Program Committee, World Glaucoma congress

Chair and founder, World Glaucoma Projects committee (WGPC)

Greece


G1. STUDENTS SUPERVISED BY CANDIDATE


Year

Name of Student

Subject

Institution

1987

Howard Weiss

Nd-YAG Laser Trabeculo-Puncture

New England Tufts Medical School

1989

Orit Brundy

Prognostic Factors in Filter Surgery

Tel Aviv University Medical School

1991

Yael Cohen

Correlation Between Retinal Vein thrombosis and Glaucoma

Tel Aviv University Medical School


G2. Ph.D. STUDENTS SUPERVISED BY CANDIDATE


Year

Name of Student

Subject

Institution

1985-6

Annelies DeKater

Trabecular Meshwork Morphology

Howe Laboratories, Harvard Medical School

1985-6

Jean Pei

Mechanism of Laser Trabeculoplasty

Howe Laboratories, Harvard Medical School

1993

D. Reingorz

Development of Improved Pilocarpine

Business School, Tel Aviv University



G3. M.D. FELLOWS SUPERVISED BY CANDIDATE (ALL FORMALLY RECOGNIZED FELLOWSHIPS OF HARVARD MEDICAL SCHOOL)


Year

Name of Student

Subject

Institution

1985-6

Chaiwat Taiwakahasee

Fibronectin in Laser Therapy

Massachusetts Eye and Ear Infirmary (M.E.E.I.) Harvard Medical School

1986-7

Ron Frenkel

Clinical Glaucoma

M.E.E.I. Harvard Medical School

1986-7

Richard Strum

Clinical Glaucoma

M.E.E.I. Harvard Medical School

1986-7

Glenn Kimball

Clinical Glaucoma

M.E.E.I. Harvard Medical School

1986-7

Michael Cheng

Clinical Glaucoma

M.E.E.I. Harvard Medical School

1987-8

Philip Fiore

Clinical Glaucoma

M.E.E.I. Harvard Medical School

1987-8

Mike Dobrogowski

Clinical Glaucoma

M.E.E.I. Harvard Medical School

1987-8

Rio Suzuki

Clinical Glaucoma

M.E.E.I. Harvard Medical School





In Israel



1990

Ruth Haim

Clinical Glaucoma

Goldschleger Eye Institute

1991

D. Rosenbaum

Clinical Glaucoma

Goldschleger Eye Institute

1992

T. Cohen

Non-Protein RGD in Wound Healing

Weizmann Institute, Rehovot

(with Dr. O. Lider)

1994

M. Goldenfeld

Ca Channel Blockers in with normal tension Glaucoma

(Dr. David Lee)

1995

S. Krupsky

ICG Angiography of the Optic Nerve

The Sam Rothberg Glaucoma Center, Goldscleger Eye Institute


2002

O. Segal

Use of OCT in Glaucoma

The Sam Rothberg

Glaucoma Center,

Goldscleger Eye Institute.






G4. RESIDENTS’ PROJECTS SUPERVISED BY CANDIDATE


Year Name of Student Glaucoma Institution


1985– 6 Peter Hersh Glaucoma Shell in Filtering M.E.E.I Harvard

Surgery Medical School


1985–6 Diana Kereten 5 – Flourouacil in Glaucoma M.E.E.I Harvard

Medical School


1987-8 Rand Allingham Laser Trabeculoplasty in M.E.E.I Harvard

Exfoliation Glaucoma Medical School


1989 Doron Neumann Pulsed – Dye Laser Filter Goldschleger Eye

in Glaucoma Institute


1989 Ami Hirsh Pulsed – Dye Laser in Goldschleger Eye

Rabbits Institute


1989 Amir Alhalel TPA ( Tissue Plasminogen Goldschleger Eye

Activitor) in Glaucoma Institute


1990 Ronit Kotas MK – 507 in Glaucoma Goldschleger Eye

Institute

1992 Shimon Kurtz Pilocarpine – Emulsion Goldschleger Eye

Ahron Grinbaum in Glaucoma Institute




1992 Adiel Barak Continuous Wave YAG Goldschleger Eye

Laser CPC and Sclerostomy Institute

In Glaucma


1993 Howard Desatnik IOP Elevation following Goldschleger Eye

Cataract Surgery Institute


1993 Adiel Barak Ethacrinic Acid following Goldschleger Eye

Cataract Surgery Institute


1993 Shimon Kurtz Adaprolol - SME in Glaucoma Goldschleger Eye

Aharon Grinbaum Institute


1993 Ami Hirsh Latanoprost ( Prostaglandin ) Goldschlager Eye

In Glaucoma Institute


1994 Hharon Grinbaum HU- 11 in Glaucoma Goldschlager Eye

Hani Verbin Institute


1994 Irina Brekute Hhmed Valve Implantation Goldschlager Eye

In Glaucoma Institute


1997 Michal Shelah Structural Changes of Optic The Sam Rothberg

Nerve in Low Tension Glaucoma Center

Glaucoma Goldschlager Eye

Institute


2002 G. Ben Simon Selective Laser

Trabeculoplasty in Glaucoma The Sam Rothberg

Glaucoma Center

Goldschlager Eye

Institute


2002 G. Ben Simon Laser Doppler Flowmetry The Sam Rothberg

In Glaucoma Glaucoma Center

Goldschlager Eye

Institute


2003 G. Ben Simon Pingelapese Achromatopsia The Sam Rothberg

Glaucoma Center

Goldschlager Eye

Institute

2003 Ori Segal Optical Coherence The Sam Rthberg

Tomography ( OCT ) Glaucoma Center

In Glaucoma Goldschlager Eye

Institute


2003 Maya Landau-Kalev Use of Radical Scavenger The Rothberg

(AD 4) in rat glaucoma model Molecu. Biology

Laboratory


2003 Noga Harizman Collapsin effect on apoptosis The Rothberg

of Ganglion Cells in rat Molec. Biology

Laboratory


2003 Amira Springer "X" syndrome and glaucoma Glaucoma Center

Goldschleger Eye

Institute



Biologists in the Glaucoma Molecular Biology Laboratory


2002 Lilach Front M.Sc. Biology Studies in Glaucoma model in rats


2002 Lea Avramova M.Sc. Biology Studies in Glaucoma model in rats.

Medical Technicians studying under supervision (with school of medical technicians)


1999 Inessa Kelner Imaging techniques in ophthalmology


1999 Hadas Irit Imaging techniques in ophthalmology


2001 Tal Yoffe Imaging techniques in ophthalmology

2002 Golan Yochi Imaging techniques in ophthalmology


2003 Yulia Luchnicher Imaging techniques in ophthalmology




G5. FELLOWS STUDYING AT LEAST ONE YEAR UNDER PROF. MELAMED’S SUPERVISION


Dr. Paula Weingarten

Buenos Aires, Argentina 1997


Dr. Audrey Kaplan

Paris, France 1997


Dr. Shimon Kurtz 1999


Dr. Ben Zion Silverstone 2003


Dr. Daniel Kotlear 2008


Dr. Zohar Bracha 2009



B1. LIST OF SCIENTIFIC PUBLICATIONS


1. Y. Kraus, S. Melamed, S.G. Sandler, M. Eliakim. A comparative study of hepattis B and non-B in hospitalized adults in an endemic area.

Israel J Medical Sciences 13: 9-14, 1977.


  1. S. Melamed, M. Lahav, U. Sandbak, Y. Yassur, I. Ben-Sira. Fuch’s

heterochromic iridocyclitis.

Invest. Ophthalmol. Vis. Sci 17: 1193-1199, 1978.


  1. Y. Yassur, S. Melamed, S. Cohen, I. Ben-Sira. Laser iridotomy in

closed angle glaucoma.

Arch. Ophthalmol. 97: 1920-1921, 1978.


  1. S. Melamed, A. Sahar, A.J. Beller. The recurrence of intracranial

meningiomas.

Neurochirurgia 22: 47-51, 1979.


  1. S. Melamed, I. Ben-Sira, Y. Ben-Shaul. Ultrastructure fenestrations in

endothelial choriocapillaris of the rabbit – a freeze fracturing study.

Br. J. Ophtholmol. 64: 537-543, 1980


  1. S. Melamed, I. Ben-Sira, Y. Ben-Shaul. Corneal endothelial changes

under induced intraocular pressure elevation – a scanning and transmission electron microscopic study.

Br. J. Ophthalmol. 64: 166-169, 1980.


  1. S. Melamed, I. Ben-Sira, Y. Ben-Shaul. Acutely elevated intraocular

pressure-effect on rabbit retinal pigment epithelium and photoreceptors.

Glaucoma 1: 59-66, 1981


  1. S. Melamed, D. Weiberger, Y. Yassur, I Ben-Sira. Timolol – effecton

intraocular pressure in chronic closed angle glaucoma, secondary glaucoma and stubborn open angle glaucoma.

Glaucoma 6: 166-170, 1984


  1. S. Melamed, J. Pei, D.L. Epstein. Q-switched Nd-YAG laser

trabecolopuncture in monkeys.

Arch. Ophthalmol. 103: 129-133, 1985


10. D.L. Epstein, S. Melamed, C. Puliafito, R. Steinert. Nd-YAG laser trabecolopuncture in open angle glaucoma.

Ophthalmology 92: 931-937, 1985



11. S. Melamed. J. Pei, D.L. Epstein. Short term effect of Argon laser trabecoloplasty in monkeys.

Arch. Ophthalmol.103: 1546-1552, 1985


12. S. Melamed, T. Freddo, D.L. Epstein. Use of cationized ferritin for tracing aqueous humor outflow.

Exp. Eye Res. 43: 273-278, 1986


13. S. Melamed. J. Pei, D.L. Epstein. Delayed response to argon laser trabecoloplasty in monkeys. Morphological study and morphometric analysis.

Arch. Ophthalmol. 104: 1078-1083, 1986


14. S. Melamed, P. Hersh, D. Kersten, D.A. Lee, D.L. Epstein. The use of glaucoma shell tamponade in leaking filtration blebs.

Ophthalmology 93: 839-842, 1986


15. S. Melamed, J. Pei, D.L. Epstein. Alteration of aqueous humor floowing algon laser trabecoloplasty in monkeys.

Br. J. Ophthalmol. 71: 776-781, 1987.


  1. S. Melamed, M.A. Latina, D.L. Epstein. Nd-YAG laser trabecoloplasty

In Juvenile glaucoma.

Ophthalmology 96: 163-170, 1987.


  1. D.A. Lee, P. Hersh, D. Kersten, S. Melamed. Complications of

subconjunctival 5-flourouracil floowing glaucoma filtration surgery.

Ophthalmic Surg. 18: 187-190, 1987.


18. S. Melamed, D.L. Epstein. The trabecular meshwork response to argon and Nd-YAG lasers. In Glaucoma Update III (ed.) G.K. Kreiglstein Springer-Verlag. Pp. 177-184, 1987.


19. S. Melamed. Alteration of trabecular aqueous flow after cataract extraction.

Ophthalmic Surg. 18: 878-881, 1987.


20. S. Melamed, J. Irvine. D.A. Lee. Intraocular pressure elevation following endartererectomy.

Ann. Ophthalmol. 19: 304-306, 1987.


21. A.C. Rosenquist, S. Melamed, D.L. Epstein. Anterior and posterior axial crystalline lens displacement on aqueous humor outflow in enucleated human eyes.

Invest. Ophthalmol. Vis. Sci. 29: 1159-1164, 1988






22. S. Melamed. Nd-YAG laser trabeculopuncture – obstacles and hopes on the way to glaucoma treatment.

Ophthal. Laser Ther. 2: 227-237, 1988.



23. S. Melamed. Argon laser trabeculoplasty, questions and answers.

Ophthalmic Practice 6: 135-136, 1988.


24. A.W. de Kater, S. Melamed, D.L. Epstein. Patterns of aqueous humor outflow in glauconatous and nonglaumatous human eyes. A tracer study using cationized ferritin.

Arch. Ophthalmol. 107: 572-576, 1989.


25. S. Melamed, C. Teekhasaenee, D.L. Epstein. Role of fibronectin in closure of YAG laser trabeculopuncture.

Lasers and Light in Ophthalmol. 2: 233-241, 1989.


26. S. Rakofsky, S. Melamed, J.S. Cohen, J.R. Slight, G. Spaeth, R. Lewis,

L. Zborowski-Gutman, E. Eto, J. Lue. A comparison of the ocular hypotensive efficacy of once daily and twice daily Levobunolol treatment.

Ophthalmology 96: 8-11, 1989.


27. J. Tauber, S. Melamed, S. Foster. Glaucoma and ocular cicatricial pemphigoid.

Ophthalmology 96: 33-37, 1989.


28. The Glaucoma Laser Trial Group (G.L.T) – S. Melamed.

I. Acute effect of argon laser trabeculoplasty in intraocular pressure.

Arch. Ophthalmol. 107: 1135-1142, 1989.


29. The Levobunolol Study Group, S. Melamed. Levobunolol – a four year study of efficacy and safety in glaucoma treatment.

Ophthalmology 96: 642-645, 1989.


30. The Levobunolol Study Group, S. Melamed. The effect of disease severity on the success rate of -blocker therapy in glaucoma.

Glaucoma 1: 109-113, 1989.


31. P. Fiore, S. Melamed. Trabeculitis and IOP rise following argon laser trabeculoplasty.

Ophthalmic Surg 2: 697-701, 1989.


32. R.C. Rosenquist, D.L. Epstein, M. Johnson, W.M. Grant, S. Melamed. Outflow resistance with variations in perfusion pressure and extent of trabeculotomy.

Current Eye Res. 8: 1233-1240, 1989.





33. J.H. Krug, S. Melamed. Use of adjustable, delayed low-dose 5-flourouacil in refractory glaucoma.

Am. J. Ophthalmol. 109: 412-418, 1990.


34. S. Melamed, I Askkenazi, M. Blumenthal. Tight scleral flap trabecolutomy with laser suture lysis.

Am. J. Ophthalmol. 103: 303-309, 1990.


  1. S. Melamed, P, Fiore. Molteno implant surgery in refractory glaucoma.

Surv. Ophthalmol. 34: 441-448, 1990.


36. The Glaucoma Laser Trial Group (G.L.T.), S. Melamed. 2. Results of argon laser trabecoloplasty versus topical medicins.

Ophthalmology 22: 324-329, 1990.


37. S. Melamed, M. Cahane, I. Gutman, M. Blumenthal. Postoperative complications of Molteno implant surgery.

Am. J. Ophthalmol 111: 319-323, 1991.


38. E. Bartov, R. Huna, S. Melamed, N. Naveh, G. Treister. Identification, prevention and treatment of silicone oil pupillary block in the presence of an inferior iridectomy.

Am. J. Ophthalmol. 111: 501-504, 1991


39. S. Melamed, I, Ashkenazi, D.L. Belcher 3rd., M. Blumenthal. Donor Scleral graft patching for persistent filtration bleb leak.

Ophthalmic Surg. 22: 164-165, 1991.


40. S. Melamed, D. Neumann, M. Blumenthal. Trabeculectomy with anterior vitrectomy in aphakic-pseudophakic glaucoma.

Int. Ophthalmol. 15: 157-162, 1991.


  1. The Glaucoma Laser Trial Group (G.L.T.), S. Melamed. The Glaucoma

Laser Trial: 3. Design and methods.

Controlled Clin. Trials 12: 504-524, 1991.


42. S. Melamed, A.W. de Kater. Glaucoma following recurrent herpes simplex kerato-uveitis – a clinicophthalmology study.

Glaucoma 13: 40-43, 1991.


43. G.L.T. Research Group, S. Melamed. The Glaucoma Laser Trial: 4 Contralateral .effect of timolol on the intraocular pressure of eyes treated with ALT.








44. S. Melamed, I. Ashkenazi, M. Blumenthal. Nd-YAG laser hyaloidotomy for malignanr glaucoma following one-piece 7 mm intraocular lens implantation.

Br. J. Ophthalmol. 75: 501-503, 1991.


45. I. Ashkenazi, S. Melamed. Risk factors associated with infected filtering blebs and endophthalmitis.

Ophthalmic Surg. 22: 2-4, 1991.


46. S. Melamed, D. Neumann. Internal sclerotomy in glaucoma – a new approach to glaucoma surgery.

Lesers Surg. Amd Med. 11: 440-444, 1991.


47. S. Melamed, I Ashkenazi, I. Gutman, M. Blumenthal. Nd-YAG laser trabeculopuncture in angle-recession glaucoma.

Ophthalmic Surg. 23: 31-35, 1992.



48. A. Barak, A. Alhalel, R. Kotas, S. Melamed. The protective effect of early intraoperative injection of viscoelastic material in trabeculectomy.

Ophthalmic surg. 23: 1-5, 1992.


49. S. Melamed, A. solomon, D. Neumann, M. Blumenthal, M. Belkin. Gonioscopic sclerstomy using laser ablation of dye enhanced sclera in refractory glaucoma.

Lasers and Light in Ophthalmology 4: 181-189, 1992.


50. S. Melamed, R. Kotas-Neumann, A. Barak, D.L. Epstein. The effect of intracameral ethacrynic acid on intraocular pressure in glaucoma patients – a pilot study.

Am. J. Ophthalmol. 113; 508-512, 1992.


51. I. Ashkenazi, S. Melamed, M. Blumenthal. The effect of coninuous strenuous excercise in intraocular pressure.

Invest. Ophthalmol. Vis. Sci. 33: 2874-2877, 1992.


52. M. latina, S. Melamed, W. march. Gonioscopic ab-interno laser sclerostomy – a pilot study in glaucoma patients.

Ophthalmology 99: 1736-1744, 1992.


53. S. Melamed, A. Solomon, D. Neumann, A. Hirsh, M. Belkin, M. Blumenthal. Laser internal sclerostomy of dye-enhanced sclera in glaucoma patients: a pilot study.

Br. J. Ophthalmol. 77: 139-144, 1993.


54. The glaucoma laser trial Group (G.L.T.), S. Melamed. 5. Subgroup differences at enrollment.

Ophthalmic Surg. 24: 232-241, 1993.


55. S. Kurtz , S. Melamed and M. Blumenthal

Sturge Weber Syndrome – management of cataract and intraocular

Implantation following trabeculectomy.

J. of Cataract And Refractive Surgery , 19:539-541, 1993.


56. S. Melamed, A. Hirsh, A. Solomon, R. Kotas-Neumann, D.A. Lee. Gonioscopic laser sclerostomy of sclera dued with Methylene-blue and reactive black – a tracer study in cats cationized ferritin.

Lasers and Light in Ophthalmology 5: 185-191, 1993.


57. I. Gutman, S. Melamed, I. Ashkenazi, M. Blumenthal. Optic nerve comparisson by carotid atreries in low tension glaucoma.

Arch. Von. Graeffe Ophthalmol. 231: 711-717, 1993.


58. R. Hershkovitz, S. Melamed, N. Greenbaum, O.Lider. Non-peptidic analog of the ARG-GLY-ASP (RGD) sequences specifically inhibits the adhesion of human tenon capsules fibroblasts to fibronectin.

Invest. Ophthalmol. Vis. Sci. 35(5): 2585-2591, 1994.


59. A. Barak, M. Rosner, S. Melamed. The use of giant pulse Nd-YAG laser for Ab-externo laser sclerostomy.

Ophthalmoc Surg. 26: 68-72, 1995.


60. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial

(GLT): 6. Treatment group differences in visual field changes.

Am. J. Ophthalmol. 120: 10-22, 1995.


61. E. Strahlman, R. Tipping, R. Vogel and the International Dorzolamide Study Group. A double-masked, randomized 1 year study comparing Dorzolamide (Trusopt), Timolol and Betaxolol.

Arch. Ophthalmol. 113: 1009-1016, 1995.


62. S. Melamed, The Glaucoma Laser Trial (GLT) and Glaucoma Trial follow-up study: 7. Results.

Am. J. Ophthalmol 120: 718-7231, 1995.


63. J. Moisseiev, H. Desatnik, Y. Cohen, S. Melamed. The influence of glaucoma on visual prognosis of central and branch vein occlusion.

Acta Ophthalmologica 74: 368-371, 1996.



64. A. Barak, H. Desatnik, T. Ma-Naim, I Ahkenazi, A.H. Neufeld, S. Melamed. Early postoperative intraocular pressure pattern following cataract surgery.

J. Refract. & Cat. Surg. 23: 607-611, 1996.



65. T. Wygnanski,-Jaffa, A. Barak, S. Melamed, Y. Glovinsky. Intraocular pressure increments after cataract extraction in glaucomatous eyes with functioning filtering blebs.

Ophthalmic Syrg. 28: 818-822, 1997.


66. Levkovitch-Verbin, M. Goldenfeld, S. Melamed. Fornix-based

trabeculectomy with mitomycin C submmited to lasers and ophthalmic surgery.

Ophthalmol. Surg. 28: 818-822, 1997.



67. M. Lusky, V. Ticho, Y. Glovinsky, R. Nesher, S. Melamed. A comparative study of 2-dose regimen of Latanoprost in patients with elevated IOP.

Ophthalmology, 104:1720-24,1997


68. S. Melamed, S. Krupsky, H. Verbin-Levkovitch, G. Treister. Confocal tomographic angiography of the optic nerve head: A new method for evaluating superficial and deep vessels of the optic disc.

Am. J. Ophthalmol. 125: 447–56, 1998.


69. S. Melamed, R. David.

Ongoing clinical assessment of the safety profile and efficacy of Brimonidine compared with Timolol: Year three results.

Clinical Therapeutics 22(1): 1-9: 2000


  1. Kurtz, M. Goldenfeld, S. Melamed.

Early detection of Glaucoma using a mobile unit.

Harefuah, 138: 273-6,2000.


71. A. Shirvan, M. Kimron, V. Holdengreber, Y. Ben - Shaul, S. Melamed, E. Melamed, A. Barzilai and A. Salomon.

Anti Sembaza antibodies rescue retinal ganglion cells from cell death following

Optic nerve axotomy.

J. Biol Chemistary, 277 (51 ): 799 – 807, 2002.



72. S.Melamed, G. Ben – Simon and H. Levkovitz Verbin

Selective Laser Trabeculoplasty ( SLT ) as primry treatment in Glaucoma

Arch. Ophthalmol. , 121: 957 – 960, 2003.


73. Ben – Simon, I. Moroz, M. Goldenfeld and S. Melamed.

Scanning Laser Doppler flowmetry of perfused and non – perfused recions of the Optic Nerve in Glaucoma.

Ophthalmic Surgery ,Lasers and Imaging, Vol. 34 : 245- 250, 2003.


  1. G. Ben – Simon , F.A. abraham and S. Melamed

Pingelapese Achromatopsia – paradoxical pupillary response and its correlation to clinical features.

Brit. J. Ophthalmol., 88: 223-225, 2004.



  1. H. Verbin-Levkovitch, H.A. Quigley, K.R.G. Martin,

D.F. Valenta , N. Harizman, M.E. Pease and S. Melamed

The Transcription Factor C-JUN is activated in Retinal Ganglion Cells in

Experimental Rat Glaucoma.

Experimental Eye Research , 663-670, 2005.



76. N. Harizman, R. Ben Cnaan, M. Goldenfeld and S. Melamed

Donor Scleral Patch for treating hypotony due to leaky or overfiltrating blebs.

J. Glaucoma,14: 492-496, 2005.



77. H. Levkovitch-Verbin, R. Dardik, S. Vander, and S. Melamed

Experimental Glaucoma and Optic Nerve Transection induce simultaneous Upregulation of Proapoptotic and Prosurvival Genes.

Invest. Ophthalmol. Vis. Sci. , 2491-2497, 2006.


78. A.G.P Konstas, G. Hollo, M. Irkec, S. Tsironi, I. Durukan, M. Goldenfeld and S. Melamed

Diurnal IOP control with Bimatoprost vs Latanoprost in exfoliative glaucoma: a crossover observer-masked three center study.

Br. J. Ophthalmol. , 2006.



79. H. Levkovitch-Verbin , M. Kalev-Landoy, Z. Habot-Vilner and S. Melamed

Minocycline delays death of retinal ganglion cells in experimental glaucoma and after optic nerve transection.

Arch. Ophthalmol. , 124 (4) : 520-526, 2006.


80. H. Levkovitch-Verbin, N. Harizman, R. Dardik, Y. Nisgav, S. Vander and S. Melamed

Regulation of cell death and survival pathways in experimental glaucoma.

Exp. Eye Res. , 85: 250-258 , 2007.


81. H. Levkovitch-Verbin, Z. Habot-Vilner, N. Burla, S. Melamed , M. Goldenfeld, S. Bar Sela and D. Sachs

Intraocular Pressure Elevation within the first 24 hours after cataract surgery in patients with Glaucoma or Exfoliation Syndrome.

Ophthalmology , 2007.


82. F. Topuzis, S. Melamed , H. Danesh-Meyer and the International Travoprost/TimololStudy Group

A 1 year study to compare the efficacy and safety of once – daily travoprost/timolol to once daily latanoprost/timolol in patients with open angle glaucoma or ocular hypertension.

European J opthalmol vol. 17: 183-190, 2007.




83. S. Melamed , M. Goldenfeld, G. Simon and G. Ben simon

Implantation of gold Micro Shunt into the Supraciliary Space inj glaucoma Patients – A pilot study

Archives of Ophthalmol. , 127 : 264 – 269, 2009.


84., M. Goldenfeld , S. Melamed , G.Simon and G. Ben simon

Titanium Saphire Laser Vs. Argon Laser Trabeculoplasty in patients with open angle Glaucoma.

Ophthalmic Surgery ,Lasers and Imaging 40: 264-269, 2009.


85. Y. Barkana , Z. Burgansky , Y.Gerber, S. Melamed et al.

Inter-device variability of the Stratus Optical Coherence Tomography.

Am. J Ophthalmol. 147: 260-266 , 2009.


  1. AS Konstas , G. Hollo , D. Micropoulos, S. Tsironi, AB. Haidich, T. Embeslidis, I. Georgiadou, M. Irkec and S. Melamed

Twenty-four Hour IOP control with Bimatoprost and bimatoprost/Timolol fixed Combination administered in the morning or evening in Exfoliative Glaucoma.

Brit. J. Ophthalmol. , 94: 209-213, 2010



  1. Levkovitch-Verbin H, Sadan O, Vander S, rosner M, Melamed E, Offen D and Melamed S


Intravitreal injections of Neurotrophic FactorsSecreting Mesenchymal Stem Cells are Neuroprotective in Rat Eyes following Optic Nerve Transection


Invest. Ophthalmol. Vis. Res. , 2010



  1. Goldenfeld, M, Geyer O, Segev E and Melamed S.


Selective Laser Trabeculoplasty in Pseudoexfoliative Glaucoma.

Accepted for publication in Ophthalmic Surgery and Imaging, 2010.


  1. Fabian, D , Barequet I, Goldenfeld M, Rechtman E , Roberts C and

Melamed S


IOP and Biomechanical Properties in eyes after Penetrating Keratoplasty.

Accepted for publication in American. J. Ophthalmol. , 2010.


















B2 CASE REPORTS


1. Y. Yassur, S. Melamed, I. Ben-Sira. Retinal involvement in tuberous sclerosis.

J. Pediat. Ophthalmol. 14: 379-381, 1977

2. S. Melamed, Y. Yassur, I Ben-Sira. Irido cyclectomy for intraocular malignant melanoma.

Harefuah 94: 420-422, 1978.


3. Y. Yassur, M. Snir, S. Melamed, I Ben-Sira. Bilateral maculopathy simulating “cherry red spot” in a patient with Crohn’s disease.

Br. J. Ophthalmol. 65, 184-188, 1981.


4. S. Melamed, E. Barraquer, D.L. Epstein. Possible contribution of Nd-YAG laser iridotomy to crystalline lens dislocation.

Ann. Ophthalmol. 18: 281-282, 1986.


5. S. Melamed, J Irvine, D.A. Lee. Intraocular pressure elevation following endarterectomy.

Ann. Ophthalmol. 19: 304-306, 1987.


6. S. Melamed, M.D. Wagoner. Recurrent closure of Nd-YAG laser iridomies requiring multiple treatments in pseudophakic pupillary block.

Ann. Ophthalmol. 20: 105-108, 1988.


7. S. Melamed, R. Frenkel, J.H. Krug, R.R. Allingham. Trabeculectomy with resection of ciliary processes in glaucoma following scleral bucking.

Ophthalmic Surg. 19: 506-507, 1988.


8. P. Fiore, S. Melamed. Use of Nd-YAG laser to open an occluded Molteno tube.

Ophthalmic Surg. 20: 373, 1989.


9. P. Fiore, S. Melamed, J.H. Krug. Scleral melting as a complication of trans-scleral Nd-YAG laser cyclophotocoagulation.

Ophthalmic Surg. 20: 215-216, 1989.


10. M. Cahane, S. Melamed. G. Treister. Glaucoma in Morquio syndrome.

Br. J. Ophthalmol. 74: 1990.


11. I Ahkenazi, I. Gutman, S. Melamed, E. bartov, M. Blumenthal. Vogt Koyanagi Harada syndrome in two siblings.

Metab. Pediatr. Sys. Ophthalmol 14: 42-45, 1990.


12. R. Huna, S. Melamed, G. Treister. Retinal detachment adherent to P.C. IOL after Molteno implant surgery.

Ophthalmic Surg. 21: 854-856, 1991.



13. N. Naveh, Y. Wysenbek, A. Solomon, S. Melamed, M. Blumenthal. Anterior capsule adherence to iris leading to pseudophakic pupillary block.Ophthalmic Surg. 22: 350-351, 1991.


14. S. Kurtz, S. Melamed, M. Blumenthal. Cataract and intraocular lens implantation after remote trabeculectomy for Sturge-Weber syndrome.

J. Cat. & Refract. Surg. 19: 539-541, 1993.


15. R. Huna, A. Barak, S. Melamed. Bilateral iridocorneal endothelial syndrome presented as Cogan-Reese and Chandler’s syndrome.

J. Glaucoma 5: 60-62, 1996.


16. S. Melamed – Management of the failing filter .

Jurnal of Glaucoma, vol 10, P. 129 – 132, 2001.




B3. REVIEW ARTICLES


1. S. Melamed. Timolol – a new and promising drug for glaucoma.

Harefuah 96: 301-302, 1979.

ש. מלמד. טימולול תרופה חדשה מבטיחה לטיפול הגלאוקומה.

הרפואה 96: 301-302, 1979.


2. S. Melamed. The 6th. Visual Field Symposium Santa-Marguerita, Israel.

Arch. Ophthalmol. 104: 814-815, 1986.



3. I. Ashkenazi, S. Melamed. Implantation of Molteno valve in refractory glaucoma.

Harefuah in press, 1990.


4. S. Melamed, H. Levkovitch-Verbin. The role of confocal tomography and angiography in the diagnosis of glaucoma.

Current Concepts of Ophthalmol. 8(11): 7-12, 1997.


5. S. Melamed

Ophthalmology in Israel

Arch ophthalmology 119: 1535 – 1536, 2001.


  1. S. Melamed

Neuroprotective properties of a synthetic docosanoid, Unoprostone Isopropyl: Clinical benefits in the treatment of glaucoma

Drugs exp. Clin. Res. Vol. 28 p. 63-73 , 2002

7. S. Melamed

Selective Laser Trabeculoplasty (SLT) – Another therapeutic Option in

Glaucoma Patients.

Haain, 27-30, 2004. (Hebrew).



D. CHAPTERS IN BOOKS.


1. S. Melamed. Aqueous drainage implants.

In: Glaucoma Surgery. J. Thomas (ed.), Lippincot, Pennsylvania, 1990.


2. S. Melamed. The patient post penetrating keratoplasty.

In: Clinician’s Guide to the management of Difficult Glaucomas. E.J. Higginbotham and D.A. Lee (ed.) Blackwell Scientific Publications, Oxford, England, 1993, pp. 1161-167.


3. S. Melamed. Special surgical techniques: the use of setons in glaucoma surgery.

In: Clinician’s Guide to the management of Difficult Glaucomas. E.J. Higginbotham and D.A. Lee (ed.) Blackwell Scientific Publications, Oxford, England, 1993, pp.401-413.


4. S. Melamed, I Ashkenazi. Juvenile open angle glaucoma (Invited chapter).

In: The harvard System Principles in Ophthalmology. D. Albert and F. Jakoviec (eds.). H.C. Saunders, Philadelphia, 1993, (chapter 125),

pp. 1345-1349.


5. S. Melamed. Argon laser trabeculoplasy – its mode of action. (Invited chapter).

In: Chandler and Grant Textbook of Glaucoma. D.L. Epstein (ed.) 1995.


6. S. Melamed, H. Verbin-Levkovitch. Ethacrynic acid in glaucoma

therapy. New Development in Glaucoma, Clinics of North America. D. Lee (ed.).

W.B. Saundres Publications, pp. 335-340, 1995.


7. S. Melamed. Confocal tomographic angiography of the optic nerve in glaucoma.

In: Imaging in Glaucoma. J.S. Schuman and C. matton (eds.) Slack Publications 1996 (also on CD-Rom display).


  1. S. Melamed. Angle Laser Surgery in Glaucoma in the 21st century.

R. Weinreb, Y. Ktazawa and C. Kriellstein (eds)

Mosby LTD. pp. 219 – 223, 2000.


  1. S. Melamed and David. A. Lee

Implantation of setons in Glaucoma.

In : Clinical Guide to glaucoma management , Higginbotham and Lee Eds, Elsevir Inc. , 2003.


  1. S. Melamed and David. A. Lee

Management of the patient with Post-Penetrating Keratoplasty – Associated Glaucoma.

In : Clinical Guide to glaucoma management , Higginbotham and Lee Eds,

Elsevir Inc. , 2003.


  1. S. Melamed and Dniel Cotlear

Trabeculectomy for Glaucoma .

In: the Glaucoma Textbook, P. Shacknow ed. , 2009.



E1. INVITED PAPERS IN SCIENTIFIC MEETINGS.


1. Ultrastructure of endothelial choriocapillaris in the rabbit.

The 8th. Asio-Pacific Congress of Ophthalmology, Bangkok, Thailand, 1981.


2. Argon laser trabecoloplasty – mechanism of action.

Congress of Lasers in Ophthalmology, Jerusalem, 1984.


3. Trabecular response to Argon and Nd-YAG laser treatment.

Trabecular Meshwork Research Meeting, chatam, cape Cod, U.S.A., 1984.


4. Efficacy of Argon laser trabeculoplasty in glaucoma.

University of Lexington Ophthalmology Meeting, Kentucky, U.S.A., 1984.


5. Computerized Visual Fields in Glaucoma.

Glaucoma Update Course, Harvard Medical School, Boston, U.S.A., 1985.


6. Humphrey Visual Field Analyser in Diagnosis of Glaucoma.

Massachisetts Eye and ear Infirmary Alumni Meeting, Boston, U.S.A. 1985.


7. Biology of Laser Treatment in Glaucoma.

6th. Annual Meeting of American Society for Laser in Medicine., Boston , USA

1985.

8. Trabecular Response to Various Types of Laser Treatment.

International Congress of Glaucoma Society, Bussum, Holland, 1986.


9. Glaucoma Secondary to Uveitis.

Tufts Medical School Meeting, Boston, U.S.A., 1986.


10. Diagnostic Problems in Glaucoma.

Solving Glaucoma Dilemmas Meeting, Harvard Medical School, Boston, 1986.


11. Nd-Yag Laser Trabeculopuncture in Glaucoma.

18th. European Congress of Ophthalmology, Brussels, Belgium, 1990.


12. Filtering Surgery in Israel.

Chandler-Grant Society Meeting, Boston, U.S.A., 1990.


13. Flash Lamp-Pumped Pulsed Dye Laser Sclerotomy in Glaucoma.

International Glaucoma Meeting, Singapore, 1990.


14. Internal Sclerostomy in Refractory Glaucoma.

International Ophthalmological Research Meeting, Helsinki, Finland, 1990.


15. Laser Sclerostomy and Methylene Blue Stained Sclera.

Photorefractive Surgery Symposium, Munich, Germany, 1990.


16. Internal Laser Sclerostomy in Glaucoma Patients.

International Meeting of Lasers in Ophthalmology, san Francisco, 1991.


17. Gonioscopic Laser Sclerostomy of Sclera Enhanced with Reactive Black 5.

Advanced Ophthalmic laser Therapy, 2nd. International Laser Course,

Interlaken, Switzerland, 1992.


18. Biology of Laser-Tissue Interactions in the Iridocorneal Angle.

Lasers in Ophthalmology, Ramat-Rachel, Israel, 1992.


19. Nd-YAG Laser Sclerostomy in Glaucoma.

Italian Ophthalmological Society Meeting, Rapallo, Italy, 1993.



20. The Future of Laser Technology in Ophthalmology.

Europto lasers in Medicine Congress, Budapest, Hungary, 1993.


21. New Trends in Glaucoma Therapy.

1st. Greek Glaucoma Society Meeting, Athens, Greece, 1994.


22. The Implantation of Ahmed Valve in Glaucoma.

Surgical Workshops in Athens and Saloniki, Greece, 1994.


23. Super-Pulse Nd-YAG Laser in Glaucoma Therapy.

10th. Congress, European Society of Ophthalmology, Milano, Italy, 1995.


24. Ethacrynic Acid in Glaucoma Therapy.

10th. Congress, European Society of Ophthalmology, Milano, Italy, 1995.


25. New Implants in Glaucoma Surgery.

10th. Congress, European Society of Ophthalmology, Milano, Italy, 1995.


26. ICG Angiography of the Optic Nerve in Glaucoma.

Allergan, Irvine, 1995.


27. ICG Angiography of the Optic Nerve in Glaucoma.

Course on Imaging in Glaucoma, Boston, U.S.A., 1996.


28. Confocal Tomographic Angiography of the Optic Nerve Head in Glaucoma.

Mediterranean Ophthalmic Society Meeting, Rome, Italy, 1996.


29. The Use of Brimonidin Tartrate in Glaucoma.

European Glaucoma Society Meeting, Paris, France, 1996.


30. The Use of Ahmed Valve in Glaucoma.

Indian Ophthalmological Meeting, Ahmed Abad, India, 1997.


31. Rescula in Glaucoma.

The Philippines Glaucoma Society Meeting, Manila, 1998.


32. Brimonidine – A New Alpha Agent.

Greek Glaucoma Society, Athens, 1999.


33. Blood Flow of the Optic Nerve.

Asia-Pacific Ophthalmology Congress, Manila, Philippines, 1999.

  1. Normal Tension Glaucoma.

The Spanish ophthalmological society, Madrid, Spain, 2000.


  1. Non perforating filtering surgery – do implants or anti – metabolites enhance the success?

Glaucoma sub – specialty day, American Academy of ophthalmology, Dallas, USA,2000.


36. Who needs the filtering bleb?

Turkish Glaucoma Society, Izmir, 2001.


37. Selective Laser Trubeculoplasty in Glaucoma, IGS, Barcelona, 2003.


  1. The Future of Glaucoma Surgery

16th meeting of German Ophthalmic Society (DOC),Nuremberg, Germany ,2003.


  1. Laser Treatment in Glaucoma

South Africa Society Meeting

Capetown , South – Africa, 2003.


40. Function and structure of the Trabecular meshwork

The Barcelona Inter-active Glaucoma Course

Girona, Spain , 2003.


  1. Schlemm's Canal Surgery.

The Turkish Ophthalmological Society Meeting,

Istanbul, Turkey, 2004.


  1. Basic Laser –tissue interactions in the trabecular meshwork.

The Turkish Ophthalmological Society Meeting,

Istanbul , Turky , 2004.


  1. Selective Laser Trabeculoplasty as primary Rx for Glaucoma.

The Chinese Ophthalmological Society Meeting,

Xian, China , 2004.



43. Glaucoma Golden Shunt implantation into the Supraciliary Space.

The Russian Glaucoma Society meeting, Moscow, 2004.


44. Lumigan Vs. Xalatan in PXF Glaucoma.

The Turkish Glaucoma society meeting,Antalya, Turkey , 2004.




E2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS


  1. Papers Published as Full Length Congress Proceedings


1. Ultrastructure of endothelial choriocapillaris in the rabbit.

Proceedings of the 8th Asio-Pacific Congress of Ophthalmology.


2. Argon laser trabeculoplasty and Nd-YAG laser treatment of the trabecular meshwork.

Proceedings of the 18th European Ophthalmology Congress, Brussels, Belgium.


  1. Papers Published as Abstracts


1. S. Melamed, J. Pei, D.L. Epstein. Nd-YAG laser trabeculopuncture in monkeys.

Invest. Ophthalmol. Vis. Sci. 25 (ARVO Suppl): 122, 1984.


2. R.C. Rosenquist, S. Melamed, D.L. Epstein. Decrease in facility of aqueous outflow following anterior lens displacement in excised human eyes.

Invest. Ophthalmol. Vis. Sci. 25 (ARVO Suppl): 122, 1984.


3. S. Melamed, J. Pei, D.L. Epstein. Argon Laser trabeculoplasty in monkeys.

Invest. Ophthalmol. Vis. Sci. 26 (ARVO Suppl): 159, 1985.


4. A.W. deKater, S. Melamed, D.L. Epstein. Perfusion of cationized ferritin in glaucomatous and non-glaucomatous eyes.

Invest. Ophthalmol. Vis. Sci. 28 (ARVO Suppl): 132, 1987.


5. R.R. Allingham, R. Sturm, J.H. Krug Jr., S. Melamed, D.L. Epstein. Comparative study of argon laser trabeculoplasty in pseudoexfoliation.

Am. Acad. Ophthalmol. 1988.


6. J.H. Krug Jr., S. Melamed. Use of adjustable low-dose 5-FU in refractory Glaucoma.

Am. Acad. Ophthalmol. 1988.


7. S. Melamed, L. Zborwsky-Gutman, G. Novack. A double-masked randomized study of 0.5% levobunolol given once vs. twice per day in glaucoma.

Am. Acad. Ophthalmol. 1988.


8. S. Melamed. Nd-Yag laser treatment for glaucoma. Societe Ophthalmologique Belge des Lentilles de Contact et Implants Intraoculaires (SOBEVECO) Meeting, Brusseles, Belgium, 1988.


9. S. Melamed, J. Irvine.Increased intraocular pressure following endarterectomy.

Glaucoma Abstracts, E.L. Greve (ed.). 5: 57, 1988.


  1. S. Melamed, M.D. wagoner. Recurrent closure of Nd-YAG laser

iridotomies requiring multiple treatments in pseudophakic pupillary block.

1 International Synopsis 1988. 2. Ophthalmology Digest, 1988.


11. S. Melamed, D.L. Epstein. Alterations of aqueous humor outflow following argon laser trabeculoplasty in monkeys.

Glaucoma Abstracts, E.L. Greve (ed.), 5: 84, 1988.


12. S. Melamed. Trabeculectomy with resection of ciliary processes in glaucoma following scleral buckling.

International Synopsis, 1989.


13. R.R. Osment, Z.G. Liaw, J.H. Krug, S. Melamed, M. Latina. Use of tissue plasminogen activator in experimental filtration surgery.

Invest. Ophthalmol. Vis. Sci. (Suppl) 30: 418, 1989.


14. P.M. Fiore, S. Melamed, D.L. Epstein. Trabecular precipitates and elevated intraocular pressure following argon laser trabeculoplasty.

Glaucoma Abstracts, E.> Greve (ed.) 3: 94, 1990.


15. S. Melamed, D. Neumann, A. Solomon, M. Belkin, M. Blumenthal. Internal laser sclerostomy of dye enhanced sclera in glaucoma patients – a pilot study.

Invest. Ophthalmol. Vis. Sci. (Suppl) 32: 859, 1991.


16. M.L. Latina, S. Melamed, W.F. March. Gonioscopie AB-interno sclerostomy: a pilot study in glaucoma patients.

Am. Acad. Ophthalmol., 1991.


17. P.M. Fiore, J.A. Arnoult. A.R. Bellows, B.J. Shingleton, S. Melamed. Management of exposed and extruding Molteno implants.

Am. Acad. Ophthalmol., 1991.



18. S. Melamed, I Ashkenazi, C.D. Belcher, M. Blumenthal. Donor scleral graft patching for persistent extraction bleb leak.

Glaucoma Abstracts, E.L. Greve (ed.) 3: 104, 1991.


19. R. Huna, S. Melamed, A, Hirsh, G. Treister. Retinal detachment adherent to posterior chamber IOL after Molteno implant surgery.

Glaucoma Abstracts, E.L. Greve (ed.) 3: 108, 1991.


20. S. Melamed, M. Caxhane, I Gutman, M. Blumenthal. Postoperative complications after Molteno implant surgery.

Glaucoma Abstracts, E.L. Greve (ed.) 3: 108, 1991.


21. S. Melamed. The International Glaucoma Symposium – a report.

Glaucoma Abstracts, E.L. Greve (ed.) 3: 8-10, 1991.


22. J. Moisseiev, H. Desatnik, Y. Cohen, S. Melamed. The influence of glaucoma on visual prognosis of central and branch vein occlusion.

Glaucoma abstracts, E.L Greve ( ed. ) 3:25, 1991.


  1. S. Melamed, R. Kotan-Neumann, A. Barak, D.L. Epstein. Intracameral

injection of ethacrynic acid in refractory glaucoma.

Invest. Ophthalmol. Vis. Sci. 33(Suppl): 1247, 1992.


24. S. Melamed, D. Neumann, M. Blumenthal. Trabeculectomy with anterior vitrectomy in aphakic and pseudophakic glaucoma.

Clinical Digest Series. E.L. Greve (ed.) 3(1): 84, 1992.


25. S. Melamed, S. Kurtz, A. Grinbaum, M. Vered, N. Garty. Pilocarpine-SME in sub-micron emulsion.

Invest. Ophthalmol. Vis. Sci. 34 (Suppl): 1993


26. N. Garty, S. Melamed, S. Kurtz, A. Grinbaum. Adaprolol maleate in sub-micron emulsion – a novel soft-blocking agent.

Am. Acad. Of Ophthalmol. 1993


27. S. Melamed, A. Grinbaum, N. Garty. Safety and efficacy of Adaprolol in normal subjects.

Invest. Ophthalmol. Vis. Sci. 35, 1994.


28. A. Barak, M. Rosner, A. Solomon, S. Melamed. Giant-pulse Nd-YAG laser sclerostomy.

Proceedings of Laser Applications in Ophthalmology. SPIE Series, pp. 59-169, 1993.


29. S. Melamed, S. Kurtz, A. Grinbaum, J.F. Howes, R. Neumann, N. Garty. Adaprolol maleate in sub-micron emulsion - a novel soft-blocking agent.

Invest. Ophthalmol. Vis. Sci. (Suppl), 1994.





30. E.R. Strahlman, E.A. Lippa, R.W. Tipping, and the Dorzolamide Beta-blockers Comparison Study Group (S. Melamed).

A Controlled Clinical Trial of 2% Dorzolamide (MK-507) compared to Timolol and Betaxolol.

Invest. Ophthalmol. Vis. Sci. (Suppl), 1995.


31. S. Melamed, S. Krupsky, H. Verbin, G. Treister. Confocal tomographic angiography with ICG of the optic nerve head.

Invest. Ophthalmol. Vis. Sci. (Suppl), pp. S222, 1996


32. S. Krupsky, H. Verbin, G. Treister, S. Melamed. Correlation between vascularization of optic nerve head and visual fields.

Invest. Ophthalmol. Vis. Sci. (Suppl). Pp. S462, 1996.


33. A. Barak, S. Krupsky, S. Kurtz, S. Melamed, F.A. Abraham, G. Treister. Digital indocyanine angiography in anterior ischemic optic neuropathy.

Invest. Ophthalmol. Vis. Sci. (Suppl) pp. S1085, 1996.


  1. Belkin M., Solberg Y., Treister G., Melamed S., Horm E., and Gil T.

Mapping of retinal oxygen saturation using the retinal cube spectral analysis system. Proceedings of the international society for eye research volume 14. Santa Fe, New Mexico, USA, Oct 15 – 20, 2000.


35. S. Melamed, I. Bossawska, C. Laroche

Effective of Bimatoprost ( LUMIGAN ) as Adjunctive Therapy with topical beta- blockers in patients with Glaucoma or Ocular Hypertension.

Invest. Ophthalmol. Vis. Sci. ( Suppl ) – 2002.



G1. BOOKS EDITED


1. S. Melamed. Glaucoma Update-Laser, Surgical, Medical, harvard Medical School Continuing Education, Boston, 1985.


2. S. Melamed. Proceedings of Laser Applications in Ophthalmology.

SPIE Europto Series, 1994.


3. R. Brancato, A.F. Fercher, S. Melamed, P.S. Rol. Proceedings of Cases in Ophthalmology II.

SPIE Europto Series, 1994.


4. S. Melamed

Einaim – Innovations in Diagnosis and Treatment. (In Hebrew)

Aurora Publications, 2000.


5. S. Melamed , Tanuj Dada, Ahmad Khalil


Glaucoma – in series: Instant Clinical Diagnosis in Ophthalmology


Jaypee brothers medical publishers Ed. , 2008.


  1. Ashok Garg, S. Melamed Eds.


Glaucoma Surgery

JayPee Medical Publishers , 2010.











H. LETTERS TO THE EDITORS


1. S. Melamed. Repopulation of trabecular cells after argon laser trabeculoplasty.

Am. J. Ophthalmol. 108: 209-210, 1989.


2. S. Melamed. Laser therapy in glaucoma and anterior chamber.

The Eye, Vol. 4, 1985.


2. ש. מלמד. טיפולי לייזר בגלאוקומה ובלשכה הקדמית. חלק א'.

העין, גליון 4, דצמבר 1985


3. S. Melamed. Laser therapy in glaucoma and anterior chamber.

The Eye, Vol. 5, 1986.



3. ש. מלמד. טיפולי לייזר בגלאוקומה ובלשכה הקדמית. חלק ב'.

העין, גליון 5, אפריל 1986.


4. S. Melamed, I Ashkenazi, Y. Glovinsky, M. Blumenthal. Response to “Tight scleral flap trabeculectomy with post-operative suturelysis”.

Am. J. Ophthalmol. 110: 98-99, 1990.



5. S. Melamed, I Askkenazi. Molteno implants for causing drainage in the anterior chamber in glaucoma.

The Eye, Vol. 12, 1990.


6. ש. מלמד, י. אשכנזי. שתלים לניקוז לשכה קדמית בגלאוקומה מסתם מולטנו.

העין, גליון 12, 1990.


7. S. Melamed, R. Huna, I. Avi. Molteno implant followed by penetrating keratoplasty in corneal graft failure and glaucoma.

Ophthalmic Surg. 21: 670-671, 1990.


8. A. Alhalel, A, Hirsh, S. Melamed, M. Blumenthal. Spontaneous bilateral acute angle closureglaucoma in herpes zoster.

Br. J. Ophthalmol. 75: 510, 1991.


9. S. Melamed. The International Symposium on Glaucoma, August 18-22, Jerusalem, Israel.

The Eye, 14: 32-33, 1992.


10. S. Kurtz, I. Ashkenazi, S. Melamed. Major depressive episode secondary to antiglaucoma drugs.

Am. J. Psychiatry 150: 524-525, 1993.


11. S. Melamed, M. Goldenfeld Anatomic consideration of the Ahmed Valve.

Arch. Ophthalmol. 114: 1298-1299, 1996.



12. H. Levkovitch – Verbin and S. Melamed

Treatment of Glaucoma and Cataract: Combined procedure in Glaucoma

Perspectives in practice, Issue 4.1, page 6, 2002.


  1. S. Melamed , G. Ben-Simon and H. Levkovitch-Verbin

Selective Laser Trabeculoplasty as Primary Treatment in Glaucoma.

In Press, Arch. Ophthalmol. , 2004.





EUROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION IEVA GRUNDSTEINE
SOCIAL SCIENCE CURRICULUM OBJECTIVES THE WEBSITE WWWTHEPROWORGNZ
Teach Engineering Stem Curriculum Lesson Designing Bridges


Tags: melamed as, s. melamed, shlomo, melamed, curriculum, vitae